Skip to content

Aurinia Pharmaceuticals AUPH Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin89.7%+1.3pp88.5%-0.5pp88.9%-0.6pp89.5%+1.3pp88.2%+0.3pp
Operating margin41.7%+4.7pp37.1%+10.7pp26.3%+6.3pp20%+7.7pp12.3%+14.3pp
Net margin100%-1.5pp101.5%+72.2pp29.3%+6.0pp23.3%+7.2pp16.1%+13.7pp
Returns
Return on equity65%+5.1pp59.9%+39.3pp20.7%+3.3pp17.3%+6.1pp11.2%+9.7pp
Return on invested capital25.2%+3.8pp21.4%+4.8pp16.7%+3.8pp12.8%+5.0pp7.9%+9.0pp
Efficiency
Asset turnover0.5×+0.1×0.4×-0.1×0.5×0.0×0.5×0.0×0.5×+0.1×
Liquidity
Current ratio5.5×+0.3×5.2×-0.5×5.8×+0.5×5.2×-0.7×5.9×+1.4×
Leverage
Debt-to-equity0.2×0.0×0.2×-0.1×0.3×0.0×0.3×0.0×0.3×0.0×
Net debt / EBITDA0.3×+0.2×0.1×-0.1×0.2×
Per Share
Book value per share$4.12-1.6%$4.19+55.9%$2.69+10.3%$2.44-0.3%$2.45-5.3%
Valuation
Market capitalization$1.97B-6.3%$2.1B+44.6%$1.45B+33.7%$1.09B-1.5%$1.1B-14.1%
Price / earnings6.6×-0.7×7.3×-11.4×18.7×
Price / sales6.6×-0.8×7.4×+2.0×5.5×+1.3×4.2×-0.3×4.5×-1.0×
Price / book3.5×-0.1×3.6×-0.4×+0.7×3.2×+0.1×3.2×-0.3×
EV / EBITDA14×-3.0×17×+0.5×16.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Aurinia Pharmaceuticals's profit margins?
Aurinia Pharmaceuticals (AUPH) runs a 89.7% gross margin and a 41.7% operating margin, with a 100.0% net margin.
Where do Aurinia Pharmaceuticals's ratios come from?
Every ratio is computed from Aurinia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.